Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 May;12(5):190-194.
doi: 10.14740/jmc3659. Epub 2021 Mar 5.

The Role of a Medical Intermediate Care Unit in the Management of Budd-Chiari Syndrome: Case Series

Marcia Cravo  1 , Daniel G Oliveira  1 , Arlindo Guimas  2 , Pedro Vita  2 , Ana Luisa Rego  2 , Rute Alves  2 , Diana Valadares  2 , Graziela Carvalheiras  2 , Miguel Ricardo  2 , Alexandre Pinto  2   3 , Helena Pessegueiro  4 , Filipe Nery  2   3   5
Affiliations
Case Reports

The Role of a Medical Intermediate Care Unit in the Management of Budd-Chiari Syndrome: Case Series

Marcia Cravo et al. J Med Cases. 2021 May.

Abstract

Budd-Chiari syndrome (BCS) has a wide spectrum of presentations, from an asymptomatic status to acute liver failure (ALF). The therapeutic approach depends on disease severity and related etiology with patients with severe forms of presentation classically managed in intensive care units (ICUs). Here, we report a series of five BCS patients managed in a medical intermediate care unit (IntCU), with three of them presenting with acute liver injury. Progression to ALF was seen in three patients, two of whom died, with one being successfully submitted to liver transplantation. IntCUs allow a 24-h patient surveillance and a prompt management of BCS, with less economic impact when compared to ICUs. Mortality was related to the presence of associated comorbidities that limited therapeutic approach.

Keywords: Acute liver failure; Budd-Chiari syndrome; Hypercoagulable state.

PubMed Disclaimer

Conflict of interest statement

All the authors declare that no conflict of interest exists.

References

    1. Aydinli M, Bayraktar Y. Budd-Chiari syndrome: etiology, pathogenesis and diagnosis. World J Gastroenterol. 2007;13(19):2693–2696. doi: 10.3748/wjg.v13.i19.2693. - DOI - PMC - PubMed
    1. Menon KV, Shah V, Kamath PS. The Budd-Chiari syndrome. N Engl J Med. 2004;350(6):578–585. doi: 10.1056/NEJMra020282. - DOI - PubMed
    1. Plessier A, Valla DC. Budd-Chiari syndrome. Semin Liver Dis. 2008;28(3):259–269. doi: 10.1055/s-0028-1085094. - DOI - PubMed
    1. Darwish Murad S, Plessier A, Hernandez-Guerra M, Fabris F, Eapen CE, Bahr MJ, Trebicka J. et al. Etiology, management, and outcome of the Budd-Chiari syndrome. Ann Intern Med. 2009;151(3):167–175. doi: 10.7326/0003-4819-151-3-200908040-00004. - DOI - PubMed
    1. Plessier A, Rautou PE, Valla DC. Management of hepatic vascular diseases. J Hepatol. 2012;56(Suppl 1):S25–38. doi: 10.1016/S0168-8278(12)60004-X. - DOI - PubMed

Publication types

LinkOut - more resources